ArticleNucleic acids research2008

siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma.

Henri de Martimprey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.